全文获取类型
收费全文 | 2623篇 |
免费 | 168篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 114篇 |
妇产科学 | 56篇 |
基础医学 | 330篇 |
口腔科学 | 78篇 |
临床医学 | 255篇 |
内科学 | 601篇 |
皮肤病学 | 45篇 |
神经病学 | 189篇 |
特种医学 | 149篇 |
外科学 | 232篇 |
综合类 | 74篇 |
一般理论 | 1篇 |
预防医学 | 212篇 |
眼科学 | 36篇 |
药学 | 177篇 |
中国医学 | 8篇 |
肿瘤学 | 225篇 |
出版年
2023年 | 12篇 |
2022年 | 51篇 |
2021年 | 72篇 |
2020年 | 34篇 |
2019年 | 68篇 |
2018年 | 81篇 |
2017年 | 53篇 |
2016年 | 47篇 |
2015年 | 67篇 |
2014年 | 79篇 |
2013年 | 109篇 |
2012年 | 113篇 |
2011年 | 126篇 |
2010年 | 83篇 |
2009年 | 77篇 |
2008年 | 135篇 |
2007年 | 121篇 |
2006年 | 124篇 |
2005年 | 128篇 |
2004年 | 93篇 |
2003年 | 95篇 |
2002年 | 77篇 |
2001年 | 75篇 |
2000年 | 81篇 |
1999年 | 72篇 |
1998年 | 51篇 |
1997年 | 34篇 |
1996年 | 45篇 |
1995年 | 27篇 |
1994年 | 24篇 |
1993年 | 20篇 |
1992年 | 28篇 |
1991年 | 41篇 |
1990年 | 26篇 |
1989年 | 46篇 |
1988年 | 40篇 |
1987年 | 45篇 |
1986年 | 44篇 |
1985年 | 30篇 |
1984年 | 23篇 |
1983年 | 23篇 |
1982年 | 13篇 |
1981年 | 14篇 |
1980年 | 16篇 |
1979年 | 11篇 |
1976年 | 12篇 |
1975年 | 11篇 |
1970年 | 10篇 |
1968年 | 10篇 |
1965年 | 10篇 |
排序方式: 共有2799条查询结果,搜索用时 0 毫秒
101.
Dietary Flavonoids Added to Pharmacological Antihypertensive Therapy are Effective in Improving Blood Pressure 下载免费PDF全文
Marina María de Jesús Romero‐Prado Ernesto Germán Cardona‐Muñoz Angeles Rios‐Arellano Lol‐Be Balam‐Salazar 《Basic & clinical pharmacology & toxicology》2015,117(1):57-64
Epidemiological studies have suggested that the daily intake of flavonoids is associated with a decreased risk of developing cardiovascular disease. Our purpose was to evaluate the effect of the addition of dietary flavonoids (DF) to antihypertensive treatment (AHT), based on telmisartan (Tms) or captopril (Cpr), on blood pressure (BP), body mass index (BMI), waist/hip ratio, leptin, lipid profile and inflammation in hypertensive young patients. An open‐label, randomized, controlled trial was performed among 79 patients aged 20–55 years with grade I or grade II systemic arterial hypertension. The subjects were assigned to one of four groups for AHT plus DF during 6 months: Cpr (n = 14), Cpr + DF (n = 19), Tms (n = 25) and Tms + DF (n = 21). DF consisted of dark chocolate, dehydrated red apple and green tea in an infusion to obtain a daily dose of 425.8 ± 13.9 mg epicatechin equivalents. The BP and anthropometric parameters were measured every 2 weeks. Lipid profile, leptin and hsCRP were determined by standard methods. The combination AHT‐DF produced an additional and significant reduction in (i) SBP/DBP of ?5/?4 mmHg, being ?7/?5 for Cpr + DF and ?4/?3 for Tms + DF; (ii) triglyceride levels (?30.6%) versus AHT alone (?9.6%); and (iii) leptin: Cpr + DF versus Tms + DF (p < 0.005). Finally, C‐reactive protein plasma levels were reduced significantly in all groups independently of the applied treatment. We conclude that the addition of flavonoids to pharmacological antihypertensive therapy shows additional benefits on BP, lipid profile, leptin, obesity and inflammation. 相似文献
102.
Cesar Homero Gutirrez‐Aguirre Dalila Marisol Alvarado‐Navarro Alain Palomares‐Leal Gerardo Mejía‐Jaramillo Rosario Salazar‐Riojas Andrs Gmez‐De Len Perla Rocío Colunga‐Pedraza Guillermo Sotomayor‐Duque Jos Carlos Jaime‐Prez Olga Graciela Cantú‐Rodríguez Luz del Carmen Tarín‐Arzaga Juan Antonio Flores‐Jimnez David Gmez‐Almaguer 《Transfusion》2019,59(12):3721-3726
103.
J Vidal-Gárate G Casta?eda Hernández C Hoyo Vadillo J E Herrera Abarca L A Salazar A Moreno Ramos J Fortino Chávez I Tena E Hong 《Archivos del Instituto de Cardiología de México》1989,59(1):73-80
The effects and pharmacokinetic parameters of two oral formulations of nifedipine, 10 mg capsule (Adaltat) and 20 mg slow release tablet (Adalat a.p.). With the 10 mg capsule nifedipine was rapidly absorbed, reaching a maximum concentration of 120 +/- 39 ng/ml in 0.52 +/- 0.07 h, and also rapidly eliminated with an apparent halflife of 5.51 +/- 0.64 h. A fall in blood pressure and a raise in heart rate, that significantly correlated with plasma levels, were observed. 83% of the subjects reported headache, that was probably due to the sudden increase in plasma levels. With the 20 mg slow release tablet nifedipine absorption was slower, reaching a maximum concentration of 39 +/- 7 ng/ml in 1.82 +/- 0.43 h, and the apparent half-life (16.89 +/- 3.14 h) was longer than with the capsule. A fall in blood pressure was observed that significantly correlated with plasma levels; however, there was no significant correlation between these and changes in heart rate. Only 17% of the subjects reported headache. Pharmacokinetic data indicate that, in most subjects, nifedipine therapeutics plasma levels (over 15 ng/ml) can be maintained with the administration of a 20 mg slow release tablet every 12 hours. This, joined to the reduction in side effects, suggest that this formulation is the adequate alternative in chronic treatments with nifedipine, such as arterial hypertension. 相似文献
104.
105.
The clinical and electrocardiographic features of 11 patients with ventricular parasystole in acute myocardial infarction are described. This arrhythmia always appeared within the first 24 hours after the beginning of the pain, and lasted usually a few hours. Only one patient received digitalis before the appearance of the arrhythmia; the others did not receive any drug of known arrhythmic potential. The treatment was mainly with lignocaine intravenously, the response to which was usually very good. 相似文献
106.
Nieves Gonzalo Carlos H. Salazar María José Pérez-Vizcayno Juan Carlos Gómez-Polo Pilar Jiménez-Quevedo Santiago Jiménez-Valero Monica Masotti Rafael Romaguera Antonio Fernández-Ortiz Javier Escaned Fernando Alfonso Carlos Macaya 《Revista espa?ola de cardiología》2021,74(5):427-435
Introduction and objectivesNeoatherosclerosis is one of the causes of in-stent restenosis (ISR). Our objective was to evaluate the influence of neoatherosclerosis on prognosis and treatment response in patients with ISR.MethodsThis is a pooled analysis of the optical coherence tomography (OCT)-substudies of 2 multicenter, randomized clinical trials, RIBS IV and V, comparing treatment with paclitaxel-coated balloon vs everolimus-eluting stent in patients with ISR. OCT evaluation was performed at baseline and at 6 to 9 months. Neoatherosclerosis was defined in baseline OCT as neointima with calcified or lipid content. We evaluated the angiographic and OCT results at 6 to 9 months and the occurrence of major adverse cardiovascular events at 3 years of follow-up in patients with and without neoatherosclerosis treated with paclitaxel-coated balloon or everolimus-eluting stents.ResultsSixty-four patients underwent OCT at the time of the index procedure. Neoatherosclerosis was documented in 23 (36%) lesions. Angiographic follow-up at 6 to 9 months showed no differences in restenosis [5 (24%) vs 6 (15%) P = .49], minimum lumen diameter (1.79 ± 0.7 vs 1.94 ± 0.6 mm; P = .41) or late loss (0.33 ± 0.7 vs 0.15 ± 0.5; P = .34) in patients with and without neoatherosclerosis, respectively. Follow-up OCT confirmed the absence of differences in quantitative parameters and the characteristics of tissue coverage between the 2 groups. At 3 years of follow-up, the major adverse cardiovascular events rate was 3 (13%) vs 5 (12%) in the neoatherosclerosis and nonneoatherosclerosis groups (HR, 0.94; 95%CI, 0.22-3.93; P = .93).ConclusionsIn this limited study population, OCT-defined neoatherosclerosis did not seem to influence acute and long-term outcomes in patients randomized to paclitaxel-coated balloon or everolimus-eluting stents for ISR. 相似文献
107.
de Salazar AO Izaguirre JL Zubero Z 《Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital》2003,30(3):225-228
We report a clinical case of multiple mycotic aneurysms, in the ascending aorta, aortic arch, and descending aorta. The patient underwent surgery to replace the ascending aorta and aortic arch by means of a highly modified "elephant trunk" technique and with the aid of arterial cannulation from the right subclavian artery, which provided antegrade cerebral perfusion. Samples of purulent material taken from the aneurysmal wall yielded cultures positive for Staphylococcus aureus. The patient was treated with antibiotics for 6 weeks and then underwent a 2nd procedure for the aneurysmal resection of the descending thoracic aorta and the abdominal aorta, through a thoracic laparo-phrenicectomy. We comment on the clinical and surgical aspects of the case. 相似文献
108.
Patricia Lpez‐Arellano Keila Lpez‐Arellano Jaquelinne Luna Diana Flores Javier Jimnez‐Salazar Graciela Gavia Mario Teteltitla Juan Jos Rodríguez Alejandro Domínguez Eduardo Casas Ivan Bahena Miguel Betancourt Cristina Gonzlez Yvonne Ducolomb Edmundo Bonilla 《Environmental toxicology》2019,34(1):92-98
Perfluorooctanoic acid (PFOA) is a member of the perfluoroalkyl acid family of compounds. Due to the presence of strong carbon–fluorine bonds, it is practically nonbiodegradable and highly persistent in the environment. PFOA has been detected in the follicular fluid of women, and positively associated with reduced fecundability and infertility. However, there are no reports concerning the experimental evaluation of PFOA on oocyte toxicity in mammals. The aim of the present study was to determine if PFOA is able to induce oxidative stress in fetal ovaries and cause apoptosis in oocytes in vitro. In addition, since inhibition of the gap junction intercellular communication (GJIC) by PFOA has been demonstrated in liver cells in vivo and in vitro, the effect of PFOA on the GJIC between the oocyte and its supportive cumulus cells was studied. Results show that PFOA induced oocyte apoptosis and necrosis in vitro (medium lethal concentration, LC50 = 112.8 μM), as evaluated with Annexin‐V‐Alexa 508 in combination with BOBO‐1 staining. Reactive oxygen species (ROS) levels, as assessed by DCFH‐DA, increased significantly in fetal ovaries exposed to ¼ LC50 (28.2 μM, a noncytotoxic and relevant occupational exposure concentration) and LC50 PFOA ex vivo. This perfluorinated compound also caused the blockage of GJIC in cumulus cells‐oocyte complexes (COCs) obtained from female mice exposed in vivo, as evaluated by calcein transfer from cumulus cells to the oocyte. The ability of PFOA of disrupting the GJIC in COCs, generating ROS in the fetal ovary and causing apoptosis and necrosis in mammal's oocytes, might account for the reported association between increasing maternal plasma concentrations of PFOA with reduced fertility in women. 相似文献
109.
110.
Stephanie Popping Valeria Cento Carole Seguin-Devaux Charles A. B. Boucher Adolfo de Salazar Eva Heger Orna Mor Murat Sayan Dominique Salmon-Ceron Nina Weis Henrik B. Krarup Robert J. de Knegt Oana Sndulescu Vladimir Chulanov David A. M. C. van de Vijver Federico García Francesca Ceccherini-Silberstein 《Viruses》2022,14(1)
Background: Approximately 71 million people are still in need of direct-acting antiviral agents (DAAs). To achieve the World Health Organization Hepatitis C elimination goals, insight into the prevalence and influence of resistance associated substitutions (RAS) is of importance. Collaboration is key since DAA failure is rare and real-life data are scattered. We have established a European collaboration, HepCare, to perform in-depth analysis regarding RAS prevalence, patterns, and multiclass occurrence. Methods: Data were extracted from the HepCare cohort of patients who previously failed DAA therapy. Geno—and subtypes were provided by submitters and mostly based on in-house assays. They were reassessed using the Comet HCV subtyping tool. We considered RAS to be relevant if they were associated with DAA failure in vivo previously reported in literature. Results: We analyzed 938 patients who failed DAA therapy from ten different European countries. There were 239 genotypes (GT) 1a, 380 GT1b, 19 GT2c, 205 GT3a, 14 GT4a, and 68 GT4d infections. Several unusual subtypes (n = 15) (GT1b/g/l, GT3b, GT4k/n/r/t) were present. RAS appeared in over 80% of failures and over a quarter had three or more RAS. Multiclass RAS varied over target region and genotype between 0–48%. RAS patterns such as the Q30R + L31M and Q30R + Y93H in GT1a, the L31V + Y93H and L31V + Y93H for GT1b, and A30K + L31M and A30K/V + Y93H for GT3a all occurred with a prevalence below 5%. Conclusion: RAS occur frequently after DAA failures and follow a specific genotype and drug related pattern. Interpretation of the influence of RAS on retreatment is challenging due to various patterns, patients’ characteristics, and previous treatment history. Moving towards HCV elimination, an ongoing resistance surveillance is essential to track the presence of RAS, RAS patterns and gather data for a re-treatment algorithm. 相似文献